ANTISENSE RNA TARGETING PMP22 FOR THE TREATMENT OF CHARCOT-MARIE-TOOTH 1A DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America

APP PUB NO 20220002721A1
SERIAL NO

17279206

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antisense RNAs targeting PMP22 and able to inhibit from 40% to 60% the expression of PMP22 in the cells and a pharmaceutical composition comprising thereof. The antisense RNAs are preferably siRNA and are preferably provided in the form of nanoparticles. The present invention also relates to the use of these antisense RNAs targeting PMP22 for the treatment of Charcot-Marie-Tooth 1A disease.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3 RUE MICHEL ANGE PARIS 75015
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BOUTARY, Susan Arcueil, FR 1 0
COUVREUR, Patrick Paris, FR 40 743
DESMAËLE, Didier Fresnes, FR 1 0
MASSAAD, Charbel Arcueil, FR 2 3
MASSADE, Liliane Cachan, FR 2 1
URBINATI, Giorgia Maria Laura Paris, FR 1 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation